Know What's Happening in Healthcare

Today's Healthcare Pulse

Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform

Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.

AI Restores Voice by Reading Neck Muscle Movements
BlogApr 21, 2026

AI Restores Voice by Reading Neck Muscle Movements

Researchers at Pohang University of Science and Technology have created an AI‑driven neck sensor that reads microscopic muscle and skin movements to convert silent speech into audible voice. The device combines a miniature camera with silicone markers in a multiaxial...

By Health Tech World
Key Considerations in Healthcare Litigation Cases Today
NewsApr 21, 2026

Key Considerations in Healthcare Litigation Cases Today

The article outlines essential considerations for healthcare litigation, emphasizing patient rights, thorough medical documentation, and strict regulatory compliance. It highlights the pivotal role of expert testimony, insurance knowledge, and confidentiality safeguards in shaping case outcomes. The piece contrasts settlement advantages...

By Healthcare Guys
Endless ER Wait Leaves Mom Still Unattended
SocialApr 21, 2026

Endless ER Wait Leaves Mom Still Unattended

Spent the whole evening in the ER waiting room and we’re still waiting so that my mom gets medical attention 🫠

By The Space Mechanic
SCOTUS Conversion Therapy Decision “Opens a Dangerous Can of Worms”
BlogApr 21, 2026

SCOTUS Conversion Therapy Decision “Opens a Dangerous Can of Worms”

The U.S. Supreme Court ruled that Colorado's ban on conversion therapy for minors infringes on counselors' First Amendment speech rights, sending the case back to lower courts to determine if the law can meet strict scrutiny. The majority treats spoken...

By Science-Based Medicine
Cerebral Palsy Doctor Explains Real Impact of Policy Cuts
SocialApr 21, 2026

Cerebral Palsy Doctor Explains Real Impact of Policy Cuts

I have cerebral palsy and I’m a doctor. Here’s what policy cuts mean for patients like me. [PODCAST] http://dlvr.it/TS7zmV Podcast #PublicHealthPolicy

By Kevin Pho, MD (KevinMD)
States and Territories Left in the Dark on NDIS Savings
NewsApr 21, 2026

States and Territories Left in the Dark on NDIS Savings

Australia’s federal government is set to unveil a new package of NDIS reforms aimed at slowing the scheme’s cost growth from about 9.5% to 5‑6% per year, a move projected to save roughly $4 billion AUD ($2.6 bn USD) annually over the...

By ABC News (Australia) – Business
AstraZeneca’s Ultomiris Cuts Urine Protein in Late-Stage Kidney Disease Trial
NewsApr 21, 2026

AstraZeneca’s Ultomiris Cuts Urine Protein in Late-Stage Kidney Disease Trial

AstraZeneca announced that its rare‑blood‑disorder drug Ultomiris achieved the primary goal in a late‑stage trial for IgA nephropathy, a rare kidney disease. An interim analysis showed a statistically significant reduction in urine protein by week 34, with effects detectable as early...

By PharmaLive
Probiotics Shown to Relieve Constipation in Kids: Vietnam RCT
NewsApr 21, 2026

Probiotics Shown to Relieve Constipation in Kids: Vietnam RCT

A Vietnam‑based randomized, double‑blind trial found that two Bacillus spore probiotic liquids, LiveSpo Kids and LiveSpo Preg‑Mom, significantly eased functional constipation in preschool children. Over four weeks, the probiotic groups experienced a 3.6‑ to 4‑fold reduction in low‑frequency bowel movements,...

By NutraIngredients (EU)
Hello Inside Pushes Metabolic Health Into Mainstream Care with BARMER Deal
NewsApr 21, 2026

Hello Inside Pushes Metabolic Health Into Mainstream Care with BARMER Deal

Hello Inside, an Austrian startup, is bringing CGM‑based metabolic tracking to women’s health and has secured a partnership with BARMER, Germany’s statutory insurer covering over 9 million members, to offer the program for free. The platform combines glucose data with sleep,...

By Tech.eu – People
How Motor Architecture Shapes Surgical Hand Tool Performance
NewsApr 21, 2026

How Motor Architecture Shapes Surgical Hand Tool Performance

Portescap’s new white paper highlights motor architecture as a pivotal early‑stage decision for surgical hand‑tool design. It breaks down four core architectures—slotted, slotless, brushless DC and core‑less brushed—showing how each influences torque density, vibration, speed range and thermal management. The...

By Medical Design Briefs
Philippe Pouletty, Carvolix
BlogApr 21, 2026

Philippe Pouletty, Carvolix

Physician‑entrepreneur Philippe Pouletty, founder of Carvolix, is launching AI‑driven tools for cardiology, including a decision‑support system and a robot that places transcatheter heart valves. The company also plans a robotic device to remove brain clots. Pouletty previously founded Abivax, a...

By The Health Care Blog
Maternity Boss 'Confident' As Unit Reopens
NewsApr 21, 2026

Maternity Boss 'Confident' As Unit Reopens

The Somerset NHS Foundation Trust has reopened the maternity services and Special Care Baby Unit at Yeovil District Hospital, which were shut in May 2025 after the Care Quality Commission flagged staffing, equipment and incident‑learning deficiencies. The trust recruited additional...

By BBC News – Health
AI Companions Developed for Lonely Students in Australia
NewsApr 21, 2026

AI Companions Developed for Lonely Students in Australia

Researchers at the University of New South Wales have built two prototype AI companions, Tom and Mia, to help university students cope with loneliness. The chatbots, designed in English and Mandarin, were co‑created with Chinese student input and incorporate safeguards...

By MobiHealthNews (HIMSS Media)
Prostate Cancer - I’m Asking for some Specific Advice/Thoughts to Determine My Physical (Cell-Level Age) versus Chronological Age
BlogApr 21, 2026

Prostate Cancer - I’m Asking for some Specific Advice/Thoughts to Determine My Physical (Cell-Level Age) versus Chronological Age

The large TRAVERSE trial of about 5,200 hypogonadal men found no increase in prostate‑cancer incidence with testosterone replacement therapy—12 cases on treatment versus 11 on placebo—though the study’s 33‑month follow‑up and 60% dropout limit statistical power. Mechanistically, androgen‑receptor saturation occurs...

By Rapamycin News
Muscle Energy Recovery May Explain Fatigue in Cancer Survivors
NewsApr 21, 2026

Muscle Energy Recovery May Explain Fatigue in Cancer Survivors

A pilot study using phosphorus‑31 magnetic resonance spectroscopy (31P‑MRS) measured how quickly skeletal‑muscle mitochondria restore energy after exertion in 11 cancer survivors. Older participants (≥65) recovered about 10% slower and showed weaker grip strength, higher self‑reported fatigue, and fewer daily...

By News-Medical.Net
Fish Oil Supplements for Brain Injuries Probably Don’t Work
BlogApr 21, 2026

Fish Oil Supplements for Brain Injuries Probably Don’t Work

A pioneering study from the Medical University of South Carolina, published in Cell Reports, suggests that fish oil supplements—specifically the omega‑3 fatty acid EPA—may hinder recovery after repetitive mild traumatic brain injuries. Using a novel animal model that replicates concussion‑like...

By Genetic Literacy Project
Congressional Republicans Pushing False Claims that Over-the-Counter Birth Control Pills Are Unsafe
BlogApr 21, 2026

Congressional Republicans Pushing False Claims that Over-the-Counter Birth Control Pills Are Unsafe

Congressional Republicans are circulating misleading claims that over‑the‑counter birth‑control pills are unsafe, despite no such products existing. A new JAMA Internal Medicine study highlighted the gap between policy rhetoric and reality, noting that medication‑abortion kits are not currently available OTC....

By Genetic Literacy Project
#602: Avoidant/Restrictive Food Intake Disorder (ARFID) – Megan Hellner, DrPH, RD & Katherine Hill, MD
BlogApr 21, 2026

#602: Avoidant/Restrictive Food Intake Disorder (ARFID) – Megan Hellner, DrPH, RD & Katherine Hill, MD

In a recent Sigma Nutrition podcast, Megan Hellner, PhD, RD, and Dr. Katherine Hill dissected Avoidant/Restrictive Food Intake Disorder (ARFID), emphasizing its distinction from typical picky eating and its occurrence across all body sizes. They highlighted how ARFID often goes...

By Sigma Nutrition — Articles
Peptides / Bioregulators
BlogApr 21, 2026

Peptides / Bioregulators

The invite‑only California Peptide Club convened over 100 tech‑savvy attendees in San Francisco to discuss self‑optimization peptides, a trend now outpacing even pickleball in Google searches. Participants, ranging from clinicians to DIY biohackers, shared personal stacks and demonstrated injection techniques...

By Rapamycin News
Tourists More Likely to Undergo Unnecessary Imaging in the ED
NewsApr 21, 2026

Tourists More Likely to Undergo Unnecessary Imaging in the ED

A new study of 740,000 emergency department visits in Italy’s Trentino province (2018‑2024) shows tourists—who made up about 18% of patients—accounted for roughly 20% of all radiologic exams. Tourists faced a 32% higher odds of receiving excess imaging, with red‑triage...

By Radiology Business
Policy Expert Believes CMS Is Taking “Adversial Posture” To Medicare Advantage
NewsApr 21, 2026

Policy Expert Believes CMS Is Taking “Adversial Posture” To Medicare Advantage

At the Medicarians conference, policy analyst Tom Kornfield warned that CMS is taking an increasingly adversarial stance toward Medicare Advantage (MA) amid concerns about overpayments, fraud and political scrutiny. The agency cites $76 billion in excess payments and recent data‑validation audits,...

By MedCity News
What Is Dry Needling? And Does It Work?
NewsApr 21, 2026

What Is Dry Needling? And Does It Work?

Dry needling, an ultrathin‑needle technique targeting muscle trigger points, entered mainstream physical‑therapy after the AMA endorsed it in 2016. The method has been embraced by high‑profile athletes such as Travis Kelce and Caitlin Clark, positioning it as a fast‑acting recovery tool. However,...

By The New York Times – Well
APC-Deficient Cancer Cells Rely on Single Enzyme for Survival
NewsApr 21, 2026

APC-Deficient Cancer Cells Rely on Single Enzyme for Survival

Researchers have identified aldehyde dehydrogenase 2 (ALDH2) as a critical survival factor for colorectal cancer cells lacking functional APC. Computational screening and lab experiments show that pharmacological inhibition of ALDH2, using agents such as disulfiram, sharply reduces proliferation and induces...

By News-Medical.Net
Trial Shows Safety of Novel KIR-CAR T Therapy in Solid Tumors
NewsApr 21, 2026

Trial Shows Safety of Novel KIR-CAR T Therapy in Solid Tumors

A Phase I dose‑escalation trial of SynKIR‑110, a novel KIR‑CAR T therapy, demonstrated safety in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma. The multi‑chain design uses NK‑cell receptors to provide an on/off switch, reducing T‑cell exhaustion and side...

By News-Medical.Net
WHO-Recommended Antibiotics Ineffective for Many Neonatal Sepsis Cases
NewsApr 21, 2026

WHO-Recommended Antibiotics Ineffective for Many Neonatal Sepsis Cases

Researchers from Oxford and a network of hospitals in Pakistan, Bangladesh and Nigeria presented the BARNARDS II study at ESCMID Global 2026, revealing that the WHO‑recommended first‑line antibiotics ampicillin plus gentamicin are likely effective against only 25 % of neonatal sepsis pathogens in...

By News-Medical.Net
When a Text Message Tries to Short-Circuit the FDA
BlogApr 21, 2026

When a Text Message Tries to Short-Circuit the FDA

A text exchange between Joe Rogan and Donald Trump suggesting a quick FDA green‑light for ibogaine sparked concern about bypassing the rigorous drug‑approval process. The post explains that FDA approval is deliberately methodical, requiring phased clinical trials and safety data,...

By Dr. Rubin's Substack
Hospital System Pours $20M Into Expanding Imaging, Oncology Services
NewsApr 21, 2026

Hospital System Pours $20M Into Expanding Imaging, Oncology Services

Rochester Regional Health, a New York health system, announced a $20 million investment to expand its oncology and imaging services. An $8.9 million expansion at the Lipson Cancer Institute will double infusion bays from 10 to 20 and add a dedicated oncology pharmacy....

By Radiology Business
McKesson Secures $1.25 B Apollo Minority Stake in Medical‑Surgical Unit
NewsApr 21, 2026

McKesson Secures $1.25 B Apollo Minority Stake in Medical‑Surgical Unit

McKesson Corp announced that Apollo Funds will invest $1.25 billion for an approximately 13% minority interest in its Medical‑Surgical Solutions (MMS) business, valuing the unit at $13 billion. The deal is a cornerstone of McKesson’s plan to carve out MMS and launch...

By Pulse
Conavi Medical Secures FDA 510(k) Clearance for Hybrid IVUS‑OCT Imaging System
NewsApr 21, 2026

Conavi Medical Secures FDA 510(k) Clearance for Hybrid IVUS‑OCT Imaging System

Conavi Medical announced FDA 510(k) clearance for its next‑generation hybrid intravascular ultrasound‑optical coherence tomography system, positioning the company for a U.S. commercial rollout in the second half of 2026. The clearance opens a pathway into a global intravascular imaging market...

By Pulse
AHA Calls on HRSA to Drop 340B Rebate Pilot, Warns of $1B Cost Hit
NewsApr 21, 2026

AHA Calls on HRSA to Drop 340B Rebate Pilot, Warns of $1B Cost Hit

The American Hospital Association (AHA) has formally asked the Health Resources and Services Administration (HRSA) to abandon its proposed 340B rebate‑model pilot, arguing it would impose more than $1 billion in annual costs on safety‑net hospitals and jeopardize care for millions....

By Pulse
Tozorakimab Hits Primary Endpoint in Phase III MIRANDA COPD Trial
NewsApr 21, 2026

Tozorakimab Hits Primary Endpoint in Phase III MIRANDA COPD Trial

AstraZeneca announced that tozorakimab met the primary endpoint in the Phase III MIRANDA trial, delivering a statistically significant and clinically meaningful drop in moderate‑to‑severe COPD exacerbations. The result positions the IL‑33‑targeting biologic as a potential first‑in‑class therapy for a disease with...

By Pulse
CRISPR Screens Map Human T‑Cell Genes That Promote or Block HIV Infection
NewsApr 21, 2026

CRISPR Screens Map Human T‑Cell Genes That Promote or Block HIV Infection

Researchers at Gladstone Institutes and UCSF used genome‑wide CRISPR activation and knockout screens in primary human CD4+ T cells to map host genes that either promote or restrict HIV infection. By optimizing infection rates to about 70%, they could perturb...

By GEN (Genetic Engineering & Biotechnology News)
Trump’s Psychedelic Order Tests Review Norms
NewsApr 21, 2026

Trump’s Psychedelic Order Tests Review Norms

BioCentury’s website uses a tiered cookie system to support essential functions, personalization, marketing, advertising, and analytics. Strictly necessary cookies are always active, enabling authentication, registration, and navigation, while functional cookies enhance site features. Marketing and advertising cookies help tailor product...

By BioCentury
ER Doctors Question Band‑Aid Role Amid Systemic Failure
SocialApr 21, 2026

ER Doctors Question Band‑Aid Role Amid Systemic Failure

An ER physician with 35 years of experience said it out loud: "Have I been part of the problem rather than part of the solution? Have I just been a band-aid?" That is Kenneth Ro, and it is the quiet...

By Kevin Pho, MD
Patients Now Save Money Using Weight‑Loss Injections
SocialApr 21, 2026

Patients Now Save Money Using Weight‑Loss Injections

So I saw a Threads post yesterday and it was an interesting topic. I've spoken to my Aussie patients about this too. Dulu ingat weight loss injection = mahal. But ramai patients during consults now cakap benda sama: “Dr Dinar, I've actually been...

By Marissa Dinar, MD
AACR26 Innovative Early Stage Developments to Watch Out For
BlogApr 21, 2026

AACR26 Innovative Early Stage Developments to Watch Out For

At the AACR annual meeting in San Diego, four cutting‑edge oncology programs were showcased in a single session. Each candidate is at or just beyond the threshold for first‑in‑human trials, spanning bispecific antibodies, RNA‑based therapeutics, CRISPR‑edited cell therapies, and novel...

By Biotech Strategy Blog
Celastrol Disrupts Hsc70‑Bim to Boost Longevity, Reduce Fibrosis
SocialApr 21, 2026

Celastrol Disrupts Hsc70‑Bim to Boost Longevity, Reduce Fibrosis

Celastrol Targets Hsc70-Bim Interaction as a Novel Senolytic to Extend Lifespan and Mitigate Organ Fibrosis https://t.co/Iv51QlhH5l

By David Barzilai, MD PhD
Group Coaching Boosts Mental Health in Seniors
SocialApr 21, 2026

Group Coaching Boosts Mental Health in Seniors

Community as Medicine: A Qualitative Study of How Group Health Coaching and Social Connection Improve Mental Well-Being in Older Adults https://t.co/U8mo1sYgt1 @MDPIOpenAccess https://t.co/2HCt6wBBSm

By David Barzilai, MD PhD
Morning Brief Podcast: India's Medical Tourism Slips Off the Table
NewsApr 21, 2026

Morning Brief Podcast: India's Medical Tourism Slips Off the Table

India’s medical tourism sector is experiencing a quiet decline, with foreign patient arrivals dropping about a third since 2019—from roughly 700,000 to 500,000. The slowdown is driven by strained Bangladesh ties, visa processing delays of up to 60 days, and...

By The Economic Times – Earnings (India)
Resistance Training Cuts Fat and Boosts Grip Strength
SocialApr 21, 2026

Resistance Training Cuts Fat and Boosts Grip Strength

Exercise, nutrition, physical agent therapy in older adults with sarcopenic obesity: a systematic review and network meta-analysis RT can reduce BF% while simultaneously improving grip strength, representing an effective management strategy for sarcopenic obesity. https://t.co/p0wR2R5M1E

By David Barzilai, MD PhD
Four Overlooked AACR Early-Stage Agents Worth Watching
SocialApr 21, 2026

Four Overlooked AACR Early-Stage Agents Worth Watching

While everyone was watching KRAS, some of AACR’s promising early stage pipeline agents were easy to miss. Here's an analysis on four examples which caught my eye and are well worth watching to see how they develop in the...

By Sally Church
Nektar’s Phase II Alopecia Extension Reveals Late Responders to IL-2 Therapy
NewsApr 21, 2026

Nektar’s Phase II Alopecia Extension Reveals Late Responders to IL-2 Therapy

Nektar Therapeutics reported results from a Phase II extension study of its interleukin‑2 (IL‑2) therapy for alopecia areata. The data revealed a subset of patients who did not respond initially but achieved meaningful hair regrowth after prolonged exposure, raising the...

By BioCentury
Irregular Bedtimes Double Risk of Major Cardiac Events
SocialApr 21, 2026

Irregular Bedtimes Double Risk of Major Cardiac Events

Sleep timing irregularity in midlife: association with incident major adverse cardiac events and cardiovascular disease mortality over a 10-year follow-up 🫀Individuals with irregular bedtimes had a 2-fold higher risk of MACEs compared to those with regular bedtimes Irregular sleep midpoints? Also a...

By David Barzilai, MD PhD
Zepzelca Plus Atezolizumab Gets First‑line Approval in Australia and Singapore
NewsApr 21, 2026

Zepzelca Plus Atezolizumab Gets First‑line Approval in Australia and Singapore

Specialised Therapeutics announced regulatory approval of ZEPZELCA (lurbinectedin) combined with atezolizumab as a first‑line maintenance therapy for extensive‑stage small‑cell lung cancer in Australia and Singapore. The approvals, granted under the FDA’s Project Orbis, add a new option for a disease...

By Pulse
Cleveland Clinic Partners with Luminai to Automate Operations Across 23 Hospitals
NewsApr 21, 2026

Cleveland Clinic Partners with Luminai to Automate Operations Across 23 Hospitals

Cleveland Clinic has entered a strategic partnership with AI startup Luminai to deploy its three‑layer automation platform across the system’s 23 hospitals, serving over 15 million patients. The move targets the $1 trillion administrative burden that slows care and inflates costs, beginning...

By Pulse
UnitedHealthcare Cuts Prior Authorizations and Boosts Payments for 1,500 Rural Hospitals
NewsApr 21, 2026

UnitedHealthcare Cuts Prior Authorizations and Boosts Payments for 1,500 Rural Hospitals

UnitedHealthcare announced it will exempt roughly 1,500 rural hospitals, including all Critical Access Hospitals, from most medical prior authorizations and accelerate payments by up to 50%. The move expands a pilot program to five new states and is positioned as...

By Pulse
Tenofovir Alafenamide Cuts Biological Age in Adults
SocialApr 21, 2026

Tenofovir Alafenamide Cuts Biological Age in Adults

An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics 💫 https://t.co/FFvTmJv2zv https://t.co/DHHQ18nAmy

By David Barzilai, MD PhD
Novo Nordisk’s Etavopivat Hits Co‑Primary Endpoints in Phase 3 Sickle‑Cell Trial
NewsApr 21, 2026

Novo Nordisk’s Etavopivat Hits Co‑Primary Endpoints in Phase 3 Sickle‑Cell Trial

Novo Nordisk announced that etavopivat, its once‑daily oral pyruvate‑kinase‑R activator, met both co‑primary endpoints in the Phase 3 HIBISCUS trial, lowering annualised vaso‑occlusive crisis rates by 27% and raising hemoglobin response rates to 48.7% versus 7.2% on placebo. The data position...

By Pulse
Personalized CRISPR Therapies Could Soon Reach Thousands — Here’s How
NewsApr 21, 2026

Personalized CRISPR Therapies Could Soon Reach Thousands — Here’s How

The FDA has proposed a "plausible mechanism" pathway to streamline approval of personalized CRISPR gene‑editing therapies. The new framework would let developers test multiple patient‑specific guide RNAs within a single trial, potentially shrinking the approval timeline from four years to...

By Nature – Health Policy